Comparison of the efficacy of pimecrolimus 1% cream and hydrocortisone 1% cream in facial seborrheic dermatitis: a single-blind randomized clinical trial

Completed

• Conditions: Seborrheic dermatitis; Skin and Connective Tissue Diseases; Dermatitis

• Registration Number: ISRCTN77370654
• Lead Sponsor: Tehran University of Medical Sciences (Iran) - Center for Research and Training in Skin Diseases and Leprosy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-04-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with facial seborrheic dermatitis older than 8 years.

Exclusion Criteria

1. Presence of active malignancy on the facial lesion
2. Presence of any kind of active viral skin disease on the facial lesion
3. Use of oral steroids in the past two weeks
4. Use of psoralen plus ultraviolet A (PUVA), ultraviolet B (UVB), ultraviolet A (UVA), azathioprine or cyclosporin in past month
5. Application of any topical treatment in past week
6. Use of any systemic antibiotics or antifungals in past 2 weeks
7. Attending in any other research study

Study & Design

• Study Type: Interventional
• Study Design: Not specified